ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,274.28
0.33%
Dow Jones
38,912.68
0.27%
Gold vs US Dollar
2,359.89
0.21%
Brent Oil
78.885
0.41%
Bitcoin
71,212.51
0.19%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) News

Daxor (DXR)

Daxor Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DXR
DateTimeSourceHeadlineSymbolCompany
05/06/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
05/06/202413:00GlobeNewswire Inc.Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical OfficerNASDAQ:DXRDaxor Corporation
30/05/202411:43Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
16/04/202413:00GlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
15/04/202413:00GlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
10/04/202413:00GlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
01/04/202413:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
25/03/202412:00GlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
22/03/202412:00GlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
18/03/202418:18GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersNASDAQ:DXRDaxor Corporation
18/03/202418:18GlobeNewswire Inc.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023NASDAQ:DXRDaxor Corporation
11/03/202412:00GlobeNewswire Inc.Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseNASDAQ:DXRDaxor Corporation
08/03/202418:49Edgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
08/03/202413:00GlobeNewswire Inc.Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsNASDAQ:DXRDaxor Corporation
06/03/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
29/02/202422:28Edgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
29/02/202421:15Edgar (US Regulatory)Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report)NASDAQ:DXRDaxor Corporation
26/02/202413:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:DXRDaxor Corporation
12/02/202413:00GlobeNewswire Inc.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsNASDAQ:DXRDaxor Corporation
07/02/202413:00GlobeNewswire Inc.Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsNASDAQ:DXRDaxor Corporation
29/01/202413:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingNASDAQ:DXRDaxor Corporation
16/01/202413:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressNASDAQ:DXRDaxor Corporation
09/01/202413:00GlobeNewswire Inc.DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESNASDAQ:DXRDaxor Corporation
02/01/202413:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
02/01/202413:30GlobeNewswire Inc.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
06/12/202320:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202302:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202302:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202301:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202301:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
 Showing the most relevant articles for your search:NASDAQ:DXR

Your Recent History

NYSE
ADO
Adecco
BIT
P1UR98
NLBNPIT1UR98 20240621 80
BITMOT
853448
Brera Tv Dc72 Abs Sts Am...
EU
MERAF
Mercialys Domestic bond ...
EU
INCRP
Lyxor CRP Inav
NASDAQ
AAXNTXX
Bank of Montreal Autocal...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved